Analyst Ratings for Horizon Therapeutics (HZNP)

HZNP Rating Summary

  |   Expand Research on HZNP
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 4.8 / 10   Percentile Rank: 48%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/1/2023 Jefferies Akash Tewar Downgrade Hold
(Buy)		 116.50
(N/A)		 112.74
(116.30)		 3.16% Details
12/13/2022 Leerink Partners Joseph P. Schwartz Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 112.36
(116.30)		 3.51% Details